Thousands Show Their Support for Canadians with Arthritis

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Thousands Show Their Support for Canadians with Arthritis

Walk to Fight Arthritis has raised $8 million in six years

Walk to Fight Arthritis has raised $8 million to help fund The Arthritis Society's research, education and support programs

TORONTO, June 8, 2015 (GLOBE NEWSWIRE) -- Thousands of Canadians got moving on Sunday in over 25 communities across Canada for the 6th annual Walk to Fight Arthritis, raising funds to support the work of The Arthritis Society.

Arthritis affects people of every age, from every walk of life. One in six Canadians lives with the pain of arthritis today. Two thirds of people living with arthritis are of working age, and some 24,000 children and teens are affected.

"Pain-free mobility is something everyone deserves – it's essential to our quality of life," said Janet Yale, president and CEO of The Arthritis Society. "The Walk is about coming together to help our friends, neighbours and loved ones living with the chronic pain of arthritis to reclaim that freedom."

This year's walk raised $1.1 million, bringing the Walk's six-year total to $8 million raised in support of research, programs and services.

"We are on the cusp of meaningful advances in areas like osteoarthritis, pain management and personalized medicine," continued Yale, "with life-changing implications for millions of people with the disease. Today's incredible show of support from Canadians gets us closer to achieving a future free from the pain of arthritis, but there's more work still to be done."

Contributions are still being gratefully accepted at www.walktofightarthritis.ca to the end of June. Next year's Walk to Fight Arthritis will take place on Sundy June 5, 2016.

(Photo caption: Six-year-old Jacob Emerson was among thousands of people who showed up in cities across Canada for yesterday's Walk to Fight Arthritis. Over six years, the event has raised $8 million in support of The Arthritis Society. ( Photo: J.P. Moczulski )

ABOUT THE ARTHRITIS SOCIETY

The Arthritis Society has been setting lives in motion for over 65 years. Dedicated to a vision of living well while creating a future without arthritis, The Society is Canada's principal health charity providing education, programs and support to the over 4.6 million Canadians living with arthritis. Since its founding in 1948, The Society has been the largest non-government funder of arthritis research in Canada, investing nearly $190 million in projects that have led to breakthroughs in the diagnosis, treatment and care of people with arthritis. The Arthritis Society is accredited under Imagine Canada's Standards Program. For more information about The Arthritis Society and to make a donation, visit www.arthritis.ca .

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=33585

Jeff Jurmain tel: 416.979.3348 x3354 cell: 647.461.0743 email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 144

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 607

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading